PMC:7126544 / 62931-63183 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T515","span":{"begin":230,"end":242},"obj":"Disease"}],"attributes":[{"id":"A515","pred":"mondo_id","subj":"T515","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T62400","span":{"begin":2,"end":10},"obj":"Chemical"},{"id":"T20710","span":{"begin":12,"end":22},"obj":"Chemical"},{"id":"T41140","span":{"begin":24,"end":33},"obj":"Chemical"},{"id":"T44950","span":{"begin":35,"end":46},"obj":"Chemical"},{"id":"T64360","span":{"begin":48,"end":58},"obj":"Chemical"},{"id":"T12413","span":{"begin":124,"end":143},"obj":"Chemical"},{"id":"T30976","span":{"begin":124,"end":133},"obj":"Chemical"},{"id":"T65452","span":{"begin":134,"end":143},"obj":"Chemical"},{"id":"T54351","span":{"begin":250,"end":252},"obj":"Chemical"}],"attributes":[{"id":"A68590","pred":"chebi_id","subj":"T62400","obj":"http://purl.obolibrary.org/obo/CHEBI_37943"},{"id":"A69111","pred":"chebi_id","subj":"T20710","obj":"http://purl.obolibrary.org/obo/CHEBI_135876"},{"id":"A51543","pred":"chebi_id","subj":"T41140","obj":"http://purl.obolibrary.org/obo/CHEBI_68556"},{"id":"A20834","pred":"chebi_id","subj":"T44950","obj":"http://purl.obolibrary.org/obo/CHEBI_71204"},{"id":"A85523","pred":"chebi_id","subj":"T64360","obj":"http://purl.obolibrary.org/obo/CHEBI_47898"},{"id":"A7583","pred":"chebi_id","subj":"T12413","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A91349","pred":"chebi_id","subj":"T30976","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A425","pred":"chebi_id","subj":"T65452","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A58208","pred":"chebi_id","subj":"T54351","obj":"http://purl.obolibrary.org/obo/CHEBI_33382"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T60","span":{"begin":230,"end":242},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}

{"project":"LitCovid-sentences","denotations":[{"id":"T500","span":{"begin":65,"end":150},"obj":"Sentence"},{"id":"T501","span":{"begin":151,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1628","span":{"begin":12,"end":22},"obj":"Chemical"},{"id":"1629","span":{"begin":35,"end":46},"obj":"Chemical"},{"id":"1630","span":{"begin":48,"end":58},"obj":"Chemical"},{"id":"1631","span":{"begin":124,"end":143},"obj":"Chemical"},{"id":"1632","span":{"begin":182,"end":193},"obj":"Chemical"},{"id":"1633","span":{"begin":230,"end":242},"obj":"Disease"}],"attributes":[{"id":"A1628","pred":"tao:has_database_id","subj":"1628","obj":"MESH:C016163"},{"id":"A1629","pred":"tao:has_database_id","subj":"1629","obj":"MESH:C108476"},{"id":"A1630","pred":"tao:has_database_id","subj":"1630","obj":"MESH:D015251"},{"id":"A1631","pred":"tao:has_database_id","subj":"1631","obj":"MESH:C558899"},{"id":"A1632","pred":"tao:has_database_id","subj":"1632","obj":"MESH:C000596027"},{"id":"A1633","pred":"tao:has_database_id","subj":"1633","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}

{"project":"2_test","denotations":[{"id":"32143990-32032529-55637447","span":{"begin":244,"end":247},"obj":"32032529"}],"text":"g colistin, valrubicin, icatibant, bepotastine, epirubicin, etc. Some of these may be more resistant to viral mutation than lopinavir/ritonavir [133]. Stebbing et al. suggested that baricitinib may reduce both the viral entry and inflammation [134].\nLu"}